ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting

Completed · Not applicable

Conditions studied: Oncology, Extravasation

In brief

This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication starts leaking outside the vein, it can cause damage to the surrounding tissue. Using the ivWatch device may identify leaking fluid before the nurse is able to visually observe the signs or symptoms of the leaking fluid.

Key facts

Study ID: NCT06758011
Run by: Roswell Park Cancer Institute
People needed: 2400
Starts: 2023-05-17
Expected to finish: 2026-01-26
Last updated by the study team: 2026-02-17

Who can join

Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patients requiring a peripheral IV for infusion of vesicant or vesicant-like agents (chemotherapy, other vesicant medications).
PIV must be inserted
Participant (or legal representative) must understand the nature of this study and verbally consent with the Research Study Information Sheet prior to receiving any study related procedure

You may not qualify if…

Patients who are not getting a vesicant, irritant or vesicant like fluid infused.
Patients who are bruised, scarred, or tattooed in the area of the PIV.
Patients with skin integrity issues at the site of the PIV.
Patients who are on "light precautions."
Not for use in power injectors.
Not for use on mediports, implanted ports, IVAD, central lines, PICC lines.
Patients without a cancer diagnosis.

Where it is running

Roswell Park Comprehensive Cancer Center — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.